⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
Pomerantz LLP Moves Forward with Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Launches Securities Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
JSPR
Pomerantz LLP Moves Forward with Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Launches Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Pomerantz LLP Moves Forward with Class Action Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
prnewswire.com
JSPR
Pomerantz LLP Launches Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR